TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
PosttranslationalModification
|
disease |
BEFREE |
Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).
|
12045200 |
2002 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Tuberin, the protein product of the tuberous sclerosis complex-2 (TSC2) tumor suppressor gene, has been shown to directly inhibit cell growth and is expressed at high levels in normal central nervous system neurons and astrocytes.
|
9266734 |
1997 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A 34 bp deletion within TSC2 is a rare polymorphism, not a pathogenic mutation.
|
14641237 |
2003 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.
|
16237225 |
2005 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex.
|
11403047 |
2001 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A reliable cell-based assay for testing unclassified TSC2 gene variants.
|
18854862 |
2009 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
|
25432535 |
2015 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.
|
23955302 |
2013 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
According to these results, this patient should be considered as having SEGA that developed from two somatic hit mutations in TSC2, rather than being a TSC2 patient with a very small fraction of somatic mosaicism.
|
16237225 |
2005 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
PosttranslationalModification
|
disease |
BEFREE |
Activated NF-κB promoted AKT-mediated phosphorylation of the GLUT1 regulator, AKT substrate of 160kD (AS160), but was not required for AKT phosphorylation of the mTOR regulator Tuberous Sclerosis 2 (TSC2).
|
21987722 |
2011 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
|
16114042 |
2005 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations.
|
10607950 |
2000 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations.
|
10607950 |
2000 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
|
10533067 |
1999 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
|
10533067 |
1999 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.
|
20633017 |
2010 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis.
|
10942116 |
2000 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
As a model for mTORC1 activation we used gene suppression of its physiological inhibitor TSC2 (TSC2sh).
|
28969371 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.
|
28065512 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Biallelic TSC gene inactivation in tuberous sclerosis complex.
|
20498439 |
2010 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.
|
15340059 |
2004 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Careful clinical observation continues to improve understanding of the phenotype in individuals with tuberous sclerosis complex.
|
25039834 |
2014 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Central TSC2 missense mutations are associated with a reduced risk of infantile spasms.
|
22867869 |
2013 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Central TSC2 missense mutations are associated with a reduced risk of infantile spasms.
|
22867869 |
2013 |